After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
LCTX belongs to the Healthcare sector of the AMEX while operating in the Biotechnology industry. The current market capitalization of Lineage Cell Therapeutics Inc is $117.46M. A total of 1.72 million shares were traded on the day, compared to an average of 1.88M shares.
In the most recent transaction, BROADWOOD PARTNERS, L.P. bought 7,894,737 shares of LCTX for 0.76 per share on Jan 27 ’25. After the transaction, the Director now owns 49,560,992 company shares. In a previous transaction on Nov 26 ’24, Howe Jill Ann bought 15,000 shares at 0.59 per share. LCTX shares that Chief Financial Officer owns now total 25,500.
Among the insiders who bought shares, Samuel George A. III acquired of 15,000 shares on Nov 26 ’24 at a per-share price of $0.60. This resulted in the General Counsel holding 22,184 shares of LCTX after the transaction. In another insider transaction, Mulroy Michael H. bought 40,000 shares at $0.57 per share on Nov 22 ’24. Company shares held by the Director now total 298,555.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, LCTX has a high of $1.61 and a low of $0.48.
As of this writing, LCTX has an earnings estimate of -$0.03 per share for the current quarter. EPS was calculated based on a consensus of 5.0 estimates, with a high estimate of -$0.02 per share and a lower estimate of -$0.04.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. LCTX’s latest balance sheet shows that the firm has $58.36M in Cash & Short Term Investments as of fiscal 2021. There were $2.80M in debt and $47.12M in liabilities at the time. Its Book Value Per Share was $0.36, while its Total Shareholder’s Equity was $90.90M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for LCTX is Buy with a score of 4.67.
